News

How can these cross-border healthcare structures improve the quality of care received by the almost half a million Europeans who are diagnosed with a rare cancer each year?

Glioblastoma patients with a protein called oncostatin M receptor on their tumours face a particularly poor prognosis

The event will take place at the EMA headquarters in London, UK, on 30 June 2016.

Too many teenagers and young adults are dying of some types of cancer, a Europe-wide report warns.

Researchers at Umeå University in Sweden and the Cancer Registry of Norway have studied possible causes behind the development of brain tumours.

Researchers have joined together to improve understanding about one of the most rare and lethal types of cancer: adrenocortical carcinoma

Inhibition of Antiapoptotic proteins using a BH3 mimetic increases leiomyosarcoma sensitivity to doxorubicin.

Cancer research is often a long waiting game for patients

An interview with Harold J. Burstein, MD, PhD, about the incidence of male breast cancer, why screening is difficult and the latest research.

Two recently discovered compounds have shown promise in preclinical studies for treating Ewing sarcoma, a rare cancer that predominantly affects children and adolescents.

It is hoped this will give younger patients access to newer, more personalised medicines and further improve survival rates.

A major step forward for patients and their families that have long been hoping for earlier access to safe treatments for their unmet medical needs